These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38460121)

  • 1. BIN1
    Garcia-Agudo LF; Shi Z; Smith IF; Kramár EA; Tran K; Kawauchi S; Wang S; Collins S; Walker A; Shi KX; Neumann J; Liang HY; Da Cunha C; Milinkeviciute G; Morabito S; Miyoshi E; Rezaie N; Gomez-Arboledas A; Arvilla AM; Ghaemi DI; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; Swarup V; MacGregor GR; Green KN
    Alzheimers Dement; 2024 Apr; 20(4):2922-2942. PubMed ID: 38460121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Abca7
    Butler CA; Mendoza Arvilla A; Milinkeviciute G; Da Cunha C; Kawauchi S; Rezaie N; Liang HY; Javonillo D; Thach A; Wang S; Collins S; Walker A; Shi KX; Neumann J; Gomez-Arboledas A; Henningfield CM; Hohsfield LA; Mapstone M; Tenner AJ; LaFerla FM; Mortazavi A; MacGregor GR; Green KN
    Alzheimers Dement; 2024 Jul; 20(7):4914-4934. PubMed ID: 38506634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
    De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
    Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Trem2
    Tran KM; Kawauchi S; Kramár EA; Rezaie N; Liang HY; Sakr JS; Gomez-Arboledas A; Arreola MA; Cunha CD; Phan J; Wang S; Collins S; Walker A; Shi KX; Neumann J; Filimban G; Shi Z; Milinkeviciute G; Javonillo DI; Tran K; Gantuz M; Forner S; Swarup V; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; MacGregor GR; Green KN
    Mol Neurodegener; 2023 Feb; 18(1):12. PubMed ID: 36803190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.
    Henningfield CM; Arreola MA; Soni N; Spangenberg EE; Green KN
    Glia; 2022 Feb; 70(2):287-302. PubMed ID: 34643971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
    Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
    Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity promotes resilience in a mouse model of Alzheimer's disease.
    Soni N; Hohsfield LA; Tran KM; Kawauchi S; Walker A; Javonillo D; Phan J; Matheos D; Da Cunha C; Uyar A; Milinkeviciute G; Gomez-Arboledas A; Tran K; Kaczorowski CC; Wood MA; Tenner AJ; LaFerla FM; Carter GW; Mortazavi A; Swarup V; MacGregor GR; Green KN
    Alzheimers Dement; 2024 Apr; 20(4):2794-2816. PubMed ID: 38426371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer's Disease Mouse Model.
    Ahmed ME; Selvakumar GP; Thangavel R; Kempuraj D; Raikwar SP; Zaheer S; Iyer S; Zaheer A
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):363-375. PubMed ID: 32504312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling.
    Perdigão C; Barata MA; Burrinha T; Guimas Almeida C
    J Biol Chem; 2021 Sep; 297(3):101056. PubMed ID: 34375641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.
    Lin PB; Tsai AP; Soni D; Lee-Gosselin A; Moutinho M; Puntambekar SS; Landreth GE; Lamb BT; Oblak AL
    Alzheimers Dement; 2023 Jun; 19(6):2528-2537. PubMed ID: 36524682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.